ZA8993B - Medical treatment - Google Patents

Medical treatment

Info

Publication number
ZA8993B
ZA8993B ZA8993A ZA8993A ZA8993B ZA 8993 B ZA8993 B ZA 8993B ZA 8993 A ZA8993 A ZA 8993A ZA 8993 A ZA8993 A ZA 8993A ZA 8993 B ZA8993 B ZA 8993B
Authority
ZA
South Africa
Prior art keywords
medical treatment
treatment
retrovivus
deoxythymidine
azido
Prior art date
Application number
ZA8993A
Other languages
English (en)
Inventor
Charles Anthony Hart
Anthony Hart Charles
Kevin Mccarthy
Mccarthy Kevin
Samuel John Leinster
John Leinster Samuel
Christopher Douglas Green
Douglas Green Christopher
Ayad Mohamed Khala Al-Sumidaie
Mohamed Khalaf Al-Sumidai Ayad
Original Assignee
Univ Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liverpool filed Critical Univ Liverpool
Publication of ZA8993B publication Critical patent/ZA8993B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA8993A 1988-01-07 1989-01-05 Medical treatment ZA8993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888800276A GB8800276D0 (en) 1988-01-07 1988-01-07 Medical treatment

Publications (1)

Publication Number Publication Date
ZA8993B true ZA8993B (en) 1989-10-25

Family

ID=10629601

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA8993A ZA8993B (en) 1988-01-07 1989-01-05 Medical treatment

Country Status (15)

Country Link
US (1) US5223490A (de)
EP (1) EP0327200B1 (de)
JP (1) JP2761420B2 (de)
KR (1) KR900700110A (de)
CN (1) CN1034134A (de)
AT (1) ATE83378T1 (de)
AU (1) AU626284B2 (de)
CA (1) CA1331138C (de)
DE (1) DE68903840T2 (de)
DK (1) DK173766B1 (de)
GB (1) GB8800276D0 (de)
IE (1) IE63788B1 (de)
MY (1) MY104462A (de)
WO (1) WO1989006132A1 (de)
ZA (1) ZA8993B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823353D0 (en) * 1988-10-05 1988-11-09 Wellcome Found Therapeutic nucleosides
FR2649982B1 (fr) * 1989-07-20 1991-09-27 Inst Nat Sante Rech Med Membrane biologique artificielle
US5405837A (en) * 1993-05-18 1995-04-11 Indiana University Foundation Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
US5576177A (en) * 1994-03-09 1996-11-19 St. Jude Children's Research Hospital Bioassay for reverse transcriptase inhibitors
EP1174141A3 (de) * 1996-01-23 2003-04-23 ICN Pharmaceuticals, Inc. Regulierung der TH1/TH2 Cytokinexpression durch Ribavirin and Ribavirinanaloge in activierten T-Lymphocyten
ATE234103T1 (de) * 1997-12-22 2003-03-15 Schering Corp Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
US20050203156A1 (en) * 2004-03-12 2005-09-15 Wyeth Hydantoins having RNase modulatory activity
US7563905B2 (en) * 2004-03-12 2009-07-21 Wyeth Triazole derivatives and method of using the same to treat HIV infections
US7553967B2 (en) * 2004-03-12 2009-06-30 Wyeth 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
WO2005090299A2 (en) * 2004-03-12 2005-09-29 Wyeth Carbamates as hiv anti-viral agents
WO2007123579A2 (en) * 2005-12-28 2007-11-01 Translational Therapeutics Translational dysfunction based therapeutics
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
US7725227B2 (en) * 2006-12-15 2010-05-25 Gm Global Technology Operations, Inc. Method, system, and apparatus for providing enhanced steering pull compensation
TW202228724A (zh) * 2020-09-23 2022-08-01 美商昂克萊亞製藥公司 以反轉錄酶抑制劑治療癌症之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285935C (en) * 1985-03-16 1991-07-09 Janet Lister Rideout Therapeutic nucleosides
GB8506869D0 (en) * 1985-03-16 1985-04-17 Wellcome Found Antiviral compound
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
DD262802A5 (de) * 1985-09-17 1988-12-14 The Wellcome Foundation Limited,Gb Verfahren zur herstellung einer pharmazeutischen formulierung

Also Published As

Publication number Publication date
ATE83378T1 (de) 1993-01-15
JPH03503049A (ja) 1991-07-11
DK162190A (da) 1990-07-05
JP2761420B2 (ja) 1998-06-04
DK173766B1 (da) 2001-09-24
EP0327200B1 (de) 1992-12-16
IE63788B1 (en) 1995-06-14
DK162190D0 (da) 1990-07-05
AU2949889A (en) 1989-08-01
US5223490A (en) 1993-06-29
DE68903840D1 (de) 1993-01-28
KR900700110A (ko) 1990-08-11
GB8800276D0 (en) 1988-02-10
CN1034134A (zh) 1989-07-26
WO1989006132A1 (en) 1989-07-13
CA1331138C (en) 1994-08-02
MY104462A (en) 1994-04-30
EP0327200A1 (de) 1989-08-09
IE890036L (en) 1989-07-07
AU626284B2 (en) 1992-07-30
DE68903840T2 (de) 1993-06-17

Similar Documents

Publication Publication Date Title
GB8800276D0 (en) Medical treatment
FR2606631B1 (fr) Lit medical ou table medicale
AU1808488A (en) Compounds for the treatment of alzheimer's disease
GB8807775D0 (en) Coagulation treatment of fluids
HU9302384D0 (en) 2,4-diamino-quinazoline derivatives and medical preparatives containing them
DE3475266D1 (en) Table with adjustable inclination for body stretching
ZA871860B (en) Transglutaminase inhibitors
IN173057B (de)
DK168189A (da) Topisk praeparat til behandling af otopati
KR970009583B1 (en) Calcium supplements
ZA88852B (en) Use of human blood coagulation factor xiii for the treatment of ulcerative colitis
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0270782A3 (en) Therapeutic agents for the prophylaxis of tumour metastasis
GR3005231T3 (de)
DE69009989D1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
EP0407788A3 (en) Use of retinoids for the treatment and prophylaxis of immune related diseases
HUT60145A (en) Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax
AU98941S (en) A gameboard
RO105585B1 (ro) Compozitie medicamentoasa folosita in tratamentul ulcerului de gamba
PHUM6382Z (en) Composition for the treatment of pimples
AU105789S (en) Table for notation of the physical cycle of the human body